Current Report Filing (8-k)
January 22 2018 - 01:55PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
January 19, 2018
Digipath,
Inc.
(Exact
name of registrant as specified in charter)
Nevada
(State
or other Jurisdiction of Incorporation or Organization)
000-54239
(Commission
File Number)
|
|
27-3601979
(IRS
Employer
Identification No.)
|
6450
Cameron Street, Suite 113
Las Vegas, NV 89118
(Address
of Principal Executive
Offices and zip code)
(702)
527-2060
(Registrant’s
telephone
number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under
any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [
]
Item
8.01 Other Events
On
January 19, 2018, following the close of business, Digipath was notified by the State of Nevada Department of Taxation, Marijuana
Enforcement Division (the “Department”) that the Medical Marijuana Registration Certificate and Marijuana Testing
Facility License (the “Licenses”) held by the Company’s wholly-owned subsidiary, Digipath Labs, had been suspended
due to certain regulatory violations the Department found in the course of its review of Digipath Labs’ operations and procedures.
In
accordance with the Department’s notice, Digipath Labs is submitting a Plan of Correction to the Department on January 22,
2018. The Department’s notice provides for a hearing before an administrative law judge on February 15, 2018, at which Digipath
Labs will seek to have its Licenses reinstated, although Digipath is working with the Department to request expedited review and
reinstatement.
As
a result of the Department’s suspension of its Licenses, Dipath Labs’ local Business License was also suspended by
Clark County, Nevada, which has scheduled a hearing to consider such suspension on March 22, 2018. Digipath Labs is also working
with Clark County to request expedited review and reinstatement.
Digipath
Labs is seeking to have its Licenses reinstated as soon as possible. However, until Digipath Labs successfully obtains such reinstatement,
it is prohibited from conducting further laboratory testing of marijuana in the State of Nevada, and no assurance can be made
that it will be successful in its efforts to reinstate its Licenses or the timing thereof. Until the resolution of this matter,
Digipath Labs will work with other testing laboratories to ensure that its customers’ needs are met.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
Digipath,
Inc.
|
|
|
|
|
Date:
|
January 22,
2018
|
|
|
|
|
By:
|
/s/
Todd Denkin
|
|
|
Todd
Denkin
|
|
|
President
|
Digipath (PK) (USOTC:DIGP)
Historical Stock Chart
From Feb 2024 to Mar 2024
Digipath (PK) (USOTC:DIGP)
Historical Stock Chart
From Mar 2023 to Mar 2024